Researchers are exploring engineering specific virus-targeting receptors onto a patient’s own immune cells as a way to fight infectious diseases, including COVID-19.
A test in development for early detection of cancers was able to pick up a dozen of the deadliest cancer types at stages I-IV with a high degree of accuracy while also determining where the tumor was located, according to validation data announced Monday.
Boston-based Vida Ventures said Thursday that it had closed its Vida Ventures II, or Vida II fund, raising $600 million.
Cellular soldiers created using the body’s own defenses can track down and kill cancer cells that escape during surgeries, researchers report.
This could prevent metastasis and save lives, particularly in cases of triple-negative breast cancer.